Literature DB >> 18587432

The impact of methylenetetrahydrofolate reductase (MTHFR) C677T gene polymorphism on transplant-related variables after allogeneic hematopoietic cell transplantation in patients receiving MTX as GVHD prophylaxis.

E Soydan, P Topcuoglu, K Dalva, M Arat.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18587432     DOI： 10.1038/bmt.2008.184

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  3 in total

1.  NKG2D gene polymorphism has a significant impact on transplant outcomes after HLA-fully-matched unrelated bone marrow transplantation for standard risk hematologic malignancies.

Authors:  J Luis Espinoza; Akiyoshi Takami; Makoto Onizuka; Hiroshi Sao; Hideki Akiyama; Koichi Miyamura; Shinichiro Okamoto; Masami Inoue; Yoshinobu Kanda; Shigeki Ohtake; Takahiro Fukuda; Yasuo Morishima; Yoshihisa Kodera; Shinji Nakao
Journal:  Haematologica       Date:  2009-10       Impact factor: 9.941

2.  The Impact of Methylenetetrahydrofolate Reductase C677T Polymorphism on Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation with Methotrexate Prophylaxis.

Authors:  Ja Min Byun; Hea-Lim Kim; Dong-Yeop Shin; Youngil Koh; Sung-Soo Yoon; Moon-Woo Seong; Sung Sup Park; Jin Hee Kim; Yun-Gyoo Lee; Inho Kim
Journal:  PLoS One       Date:  2016-10-26       Impact factor: 3.240

3.  More severe toxicity of genetic polymorphisms on MTHFR activity in osteosarcoma patients treated with high-dose methotrexate.

Authors:  Lu Xie; Wei Guo; Yi Yang; Tao Ji; Jie Xu
Journal:  Oncotarget       Date:  2017-12-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.